TrialReader


Omega-3 and Cardiovascular Risk Factors and Kidney Related Biomarkers

NCT03197220 — Not applicable, Completed, 99 participants, Isfahan University of Medical Sciences

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

The Impact of Fish and Walnut Consumption on Cardiovascular Risk Factors in Overweight and Obese Females: A Randomized Clinical Trial

RegistryNCT03197220
StatusCompleted
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: double, treatment
Enrollment99 (Actual)
SponsorIsfahan University of Medical Sciences (Other)
ConditionsCardiovascular Risk Factor and Kidney Related Biomarkers
Interventionsfish, walnut, fish-walnut (Other)
Datesstart 2015-11-22, primary completion 2016-11-21, completion 2017-01-20, first posted 2017-06-23, last updated 2020-04-07

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Cardiovascular Risk Factor and Kidney Related Biomarkers All trials of fish All trials of walnut

-Summary

In this study, 99 overweight or obese women that referred to the Clinic Nutrition to lose weight were randomly divided into three groups according to body mass index (BMI) by random-number table (figure1). We attempted to match all three groups for BMI, probable medications, and age. Subjects were excluded if they had risk factors of cardiovascular diseases or allergic reactions to fish or walnut, or received lowering blood glucose or lipid profile agents. Also, participants with weak economic status could not enter to this study (due to the high cost of fish and walnuts). Before the start of this study, the information in the form of questionnaire about demographic, medical history, and medication use, was completed. Participants were aware about overview of this study, and completed the consent form. The NATIONAL INSTITUTED FOR MEDICAL RESEARCH DEVELOPMENT (NIMAD), approved all procedures involving human subjects. The study has been done in accordance with the ethical standards in declaration of Helsinki.

Then all of the three groups received a low-calorie diet in order to lose weight. The distribution of macronutrients was similar in three groups (carbohydrate 55%, fat 33%, and protein 17%). The amount of different fatty acids (saturated, unsaturated with mono double bond, and polyunsaturated fatty acids) intake in these diets was the same but the sources of omega-3 between these groups were different. In the first group, subjects were instructed to consume 300 gram fatty fish, such as Salmon fish during a week in two separated meals (each meal 150 gr fatty fish) and to avoid consumption of plant sources of omega-3 (soybean oil, canola, flaxseed and walnuts). In the second group, subjects were asked to consume walnuts three times a week and each time two walnuts (totally 18 walnuts/wk) and avoid the consumption of fish. And in the third group, subjects were recommended to consume 150 g fatty fish during a week and nine walnuts. The amount of omega-3 fatty acids considered in this study covered the typical recommended intake (0.3 to 0.5 g/d of EPA+DHA and 0.8 to 1.1 g/d of ALA)(14). Dietary intakes of all patients were controlled by a dietitian and they were followed for 12 weeks. Dietary intakes were assessed by three dietary records (one weekend and two week days).

Expand all sections  ·  Collapse all

+Detailed description

This is a clinical trial which conducted on over weight and obese female.

+Arms and interventions

ArmTypeInterventionsDescription
fishExperimentalOther: fish
walnutExperimentalOther: walnut
fish-walnutExperimentalOther: fish-walnut
  • fish (Other): 300 gr/week fish
  • walnut (Other): 18 walnut per week
  • fish-walnut (Other): 150 gr fish and 9 walnut per week

+Outcome measures

Primary outcomes

  • the change of biochemical factor levels [12 weeks]: Systolic and diastolic blood pressures (SBP and DBP) will measured twice after 15 min of rest in sitting and comfortably position using a standard mercury sphygmomanometer. Blood sugar (FBS) will measured on the day of blood sampling and quantified by colorimetric method by the glucose oxidize technique. hs-CRP will measured by The Immunoturbidimetry method with with a polyclonal antibody (Pars Azmoon Inc). Serum concentrations of, high-density lipoprotein cholesterol(HDL-C), low-density lipoprotein cholesterol (LDL-C) and triglyceride (TG) will quantified using commercially available enzymatic reagents (Pars Azmoon, Tehran, Iran) adapted to an autoanalyzer system (Selectra E, Vitalab, Holliston, the Netherlands).

Secondary outcomes

  • height [12 week]: meter
  • weight [12 week]: kg
  • BUN [12 WEEK]
  • creatinine [12 WEEK]

Other outcomes

  • body mass index [12 week]: BMI was calculated as body weight in kg divided by height in m2.
  • physical activities [12 week]: We asked participants to record the duration of all physical activities in 24h for three days at weeks 3, 6, 9 and 12 of the intervention. Then the recorded physical activities were multiplied by the relevant metabolic equivalents task hours per day (MET-h/d) and were calculated the MET.h/d values of all activities to obtain the value of physical activity in a day.
  • Hs-CRP [12 week]: Hs-CRP was measured by the Immunoturbidimetry method with a polyclonal antibody (Pars Azmoon Inc).
  • high-density lipoprotein cholesterol (HDL-C), LDL-C and TG [12 week]: were quantified using commercially available enzymatic reagents (Pars Azmoon, Tehran, Iran) adapted to an autoanalyzer system (Selectra E, Vitalab, Holliston, the Netherlands).

+Eligibility

Sex: Female, accepts healthy volunteers

Inclusion Criteria:

* over weight or obese

Exclusion Criteria:

* have any diseases

+Publications

  • Results publication: Fatahi S, Haghighatdoost F, Larijani B, Azadbakht L. Effect of Weight Reduction Diets Containing Fish, Walnut or Fish plus Walnut on Cardiovascular Risk Factors in Overweight and Obese Women. Arch Iran Med. 2019 Oct 1;22(10):574-583. PMID 31679359

My Notes